Dione Kawamoto

Dr. Dione Kawamoto

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2020 in Molecular Oral Microbiology
Verified
Journal Article
Closed access
PDF file
KIKARIN HITOMI ISHIKAWA
KARIN HITOMI ISHIKAWA
MBManuela Rocha Bueno
Manuela Rocha Bueno
DKDione Kawamoto
Dione Kawamoto
MSMaria Regina Lorenzetti Simionato
Maria Regina Lorenzetti Simionato
MMMarcia Pinto Alves Mayer
Marcia Pinto Alves Mayer

1 November 2020 in Cytokine
Verified
Journal Article
Closed access
DKDione Kawamoto
Dione Kawamoto
PAPâmela Pontes Lucas Amado
Pâmela Pontes Lucas Amado
EAEmmanuel Albuquerque-Souza
Emmanuel Albuquerque-Souza
MBManuela Rocha Bueno
Manuela Rocha Bueno
GVGlauber Campos Vale
Glauber Campos Vale
MMMarcia Pinto Alves Mayer
Marcia Pinto Alves Mayer

24 May 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
ACAmalia C. S. Cataruci
Amalia C. S. Cataruci
DKDione Kawamoto
Dione Kawamoto
NSNatali Shimabukuro
Natali Shimabukuro
KIKARIN HITOMI ISHIKAWA
KARIN HITOMI ISHIKAWA
EAEllen Sayuri Ando-Suguimoto
Ellen Sayuri Ando-Suguimoto
MMMarcia Pinto Alves Mayer
Marcia Pinto Alves Mayer
Periodontitis is a destructive inflammatory response triggered by dysbiosis. Lactobacillus acidophilus LA5 (LA5) may impair microbial colonization and alter the host. Thus, we evaluated the effect of LA5 on alveolar bone loss in a periodontitis murine model and investigated its effect on the oral and gut microbiomes. Porphyromonas gingivalis, Prevotella intermedia, Fusobacterium nucleatum, and Streptococcus gordonii were inoculated in C57BL/6 mice (P+), with LA5 (L+). SHAM infected controls (P- and/or L- groups) were also evaluated. After 45 days, alveolar bone loss in the maxilla and oral and gut microbiomes were determined. The administration of LA5 controlled the microbial consortium-induced alveolar bone loss. Periodontopathogens infection resulted in shifts in the oral and gut microbiomes consistent with dysbiosis, and LA5 reshaped these changes. The oral microbiome of P+L- group showed the increased abundance of Enterococaccea, Streptoccocaceae, Staphylococcaceae, Moraxellaceae, and Pseudomonadaceae, which were attenuated by the administration of LA5 to the infected group (P+L+). The administration of LA5 to otherwise non-infected mice resulted in the increased abundance of the superphylum Patescibacteria and the family Saccharamonadaceae in the gut. These data indicate L. acidophilus LA5 as a candidate probiotic for the control of periodontitis.

Verified
Journal Article
Open access
PDF file
CRCatarina Medeiros Rocha
Catarina Medeiros Rocha
DKDione Kawamoto
Dione Kawamoto
FMFernando Henrique Martins
Fernando Henrique Martins
MBManuela Rocha Bueno
Manuela Rocha Bueno
KIKARIN HITOMI ISHIKAWA
KARIN HITOMI ISHIKAWA
MMMarcia Pinto Alves Mayer
Marcia Pinto Alves Mayer
Oral bacteria are implicated not only in oral diseases but also in gut dysbiosis and inflammatory conditions throughout the body. The periodontal pathogen Aggregatibacter actinomycetemcomitans (Aa) often occurs in complex oral biofilms with Streptococcus gordonii (Sg), and this interaction might influence the pathogenic potential of this pathogen. This study aims to assess the impact of oral inoculation with Aa, Sg, and their association (Aa+Sg) on alveolar bone loss, oral microbiome, and their potential effects on intestinal health in a murine model. Sg and/or Aa were orally administered to C57Bl/6 mice, three times per week, for 4 weeks. Aa was also injected into the gingiva three times during the initial experimental week. After 30 days, alveolar bone loss, expression of genes related to inflammation and mucosal permeability in the intestine, serum LPS levels, and the composition of oral and intestinal microbiomes were determined. Alveolar bone resorption was detected in Aa, Sg, and Aa+Sg groups, although Aa bone levels did not differ from that of the SHAM-inoculated group. Il-1β expression was upregulated in the Aa group relative to the other infected groups, while Il-6 expression was downregulated in infected groups. Aa or Sg downregulated the expression of tight junction genes Cldn 1, Cldn 2, Ocdn, and Zo-1 whereas infection with Aa+Sg led to their upregulation, except for Cldn 1. Aa was detected in the oral biofilm of the Aa+Sg group but not in the gut. Infections altered oral and gut microbiomes. The oral biofilm of the Aa group showed increased abundance of Gammaproteobacteria, Enterobacterales, and Alloprevotella, while Sg administration enhanced the abundance of Alloprevotella and Rothia. The gut microbiome of infected groups showed reduced abundance of Erysipelotrichaceae. Infection with Aa or Sg disrupts both oral and gut microbiomes, impacting oral and gut homeostasis. While the combination of Aa with Sg promotes Aa survival in the oral cavity, it mitigates the adverse effects of Aa in the gut, suggesting a beneficial role of Sg associations in gut health.

1 January 2019 in Journal of Applied Oral Science
Verified
Journal Article
Open access
PDF file
MAMariana Gouvêa Latini Abreu
Mariana Gouvêa Latini Abreu
DKDione Kawamoto
Dione Kawamoto
MMMarcia Pinto Alves Mayer
Marcia Pinto Alves Mayer
VPVinicius D’aVila Bitencourt Pascoal
Vinicius D’aVila Bitencourt Pascoal
KCKarina Sampaio Caiaffa
Karina Sampaio Caiaffa
GCGabriela Alessandra da Cruz Galhardo Camargo
Gabriela Alessandra da Cruz Galhardo Camargo
Porphyromonas gingivalis is one of the most important Gram-negative anaerobe bacteria involved in the pathogenesis of periodontitis. P. gingivalis has an arsenal of specialized virulence factors that contribute to its pathogenicity. Among them, fimbriae play a role in the initial attachment and organization of biofilms. Different genotypes of fimA have been related to length of fimbriae and pathogenicity of the bacterium.

6 May 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
ASAndreia La Selva
Andreia La Selva
EAEllen Sayuri Ando-Suguimoto
Ellen Sayuri Ando-Suguimoto
AAna Paula Mariano Santos Ginez
Ana Paula Mariano Santos Ginez
TSTania Oppido Schalch
Tania Oppido Schalch
RNRenata Matalon Negreiros
Renata Matalon Negreiros
AHAnna Carolina Ratto Tempestini Horliana
Anna Carolina Ratto Tempestini Horliana
Periodontal status has been associated with infection in lung diseases such as chronic obstructive lung disease (COPD). However, evidence regarding its association with bronchiectasis remains limited, despite the shared clinical and pathophysiological characteristics between the two conditions. Therefore, the aim of the present study was to investigate whether periodontal treatment affects not only the microbiota of saliva but also that of sputum and nasal secretions in individuals with bronchiectasis. This single-center, parallel-group randomized controlled clinical trial included forty-nine individuals with bronchiectasis, who were randomly allocated using a predefined randomization sequence with allocation concealment to a conventional group (n = 26) submitted to mechanical periodontal treatment plus oral hygiene and a control group (n = 23) submitted to oral hygiene alone. Due to the nature of the intervention, participants and operators were not blinded. At the end of the study, all participants received periodontal treatment. The primary outcome was the quantitative assessment of Pseudomonas aeruginosa (P. aeruginosa), Staphylococcus aureus (S. aureus), and Porphyromonas gingivalis (P. gingivalis) in sputum. Secondary outcomes included the quantification of these microorganisms in saliva and nasal secretions, as well as clinical periodontal parameters and quality-of-life assessment. All variables were evaluated at baseline and three months after treatment. Results: Periodontal treatment improved gingival and plaque indices in the conventional group compared with the control group. However, no significant differences were observed in sputum samples for any of the microorganisms analyzed, suggesting no measurable effect on bacterial levels in the lower airways within the study period. At the end of the experimental period, levels of P. aeruginosa and P. gingivalis decreased in nasal secretions, and levels of P. aeruginosa decreased in saliva in the conventional group but not the control group. No significant differences were found in S. aureus levels between groups or overtime. Also, no significant differences in total OHIP-14 scores were observed between groups. In conclusion, periodontal treatment was associated with reductions in P. aeruginosa in nasal secretions and saliva, and P. gingivalis in nasal secretions, in individuals with bronchiectasis and periodontitis. Periodontal treatment improved gingival and plaque indices in the conventional group compared with the control group. However, no significant differences were observed in sputum samples for any of the microorganisms analyzed, suggesting no measurable effect on bacterial levels in the lower airways within the study period. At the end of the experimental period, levels of P. aeruginosa and P. gingivalis decreased in nasal secretions, and levels of P. aeruginosa decreased in saliva in the conventional group but not the control group. No significant differences were found in S. aureus levels between groups or overtime. Also, no significant differences in total OHIP-14 scores were observed between groups.